Frontiers | Soluble and Cell–Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma | Endocrinology
Salinosporamide A - Wikipedia
Proteasome Inhibitors as Sensitizing Agents for Cancer Chemotherapy - ScienceDirect
Resistance to proteasome inhibitors and other targeted therapies in myeloma - Wallington‐Beddoe - 2018 - British Journal of Haematology - Wiley Online Library
New investigational drugs with single-agent activity in multiple myeloma | Blood Cancer Journal
Structures of marizomib and its analogs and mechanism of proteasome... | Download Scientific Diagram
Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib | Journal of Medicinal Chemistry
Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs | Journal of Pharmacology and Experimental Therapeutics
Salinosporamide A - an overview | ScienceDirect Topics
Molecules | Free Full-Text | Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease | HTML
A Practical Review of Proteasome Pharmacology | Pharmacological Reviews
Structure and mechanism of action of proteasome inhibitors. (A)... | Download Scientific Diagram
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling
Cancers | Free Full-Text | Proteasome Inhibitors for the Treatment of Multiple Myeloma | HTML
Marine Drugs | Free Full-Text | Generating a Generation of Proteasome Inhibitors: From Microbial Fermentation to Total Synthesis of Salinosporamide A (Marizomib) and Other Salinosporamides | HTML
Molecular Mechanisms of Acquired Proteasome Inhibitor Resistance | Journal of Medicinal Chemistry
Marizomib | C15H20ClNO4 - PubChem
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling
Salinosporamide A - Wikipedia
New Proteasome Inhibitors in Myeloma | SpringerLink
Advances in the understanding of mechanisms and therapeutic use of bortezomib. - Abstract - Europe PMC
Exploring the role and clinical implications of proteasome inhibition in medulloblastoma - Hoerig - 2021 - Pediatric Blood & Cancer - Wiley Online Library
Overcoming drug resistance by targeting protein homeostasis in multiple myeloma
The odyssey of marine pharmaceuticals: a current pipeline perspective: Trends in Pharmacological Sciences
Frontiers | The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia | Oncology
Overcoming drug resistance by targeting protein homeostasis in multiple myeloma
